Skip to main content
SpringerLink
Log in

Impact of Endocrine Disorders on Autoimmune Diseases

  • Reference work entry
  • First Online:
Endocrinology and Systemic Diseases

Part of the book series: Endocrinology ((ENDOCR))

Abstract

Endocrine diseases are a heterogeneous group of disorders which can affect nearly any body system including the musculoskeletal system. Rheumatic manifestations of endocrine disorders may present as a definite rheumatic disease (such as pseudogout in hyperparathyroidism), as rheumatic symptoms such as arthralgia and myalgia, as positive immune serology, or may mimic rheumatic diseases (e.g., skeletal abnormalities in hypoparathyroidism can mimic ankylosing spondylitis). The rheumatic manifestations may result from a direct effect of the hormones, the occurrence of several autoimmune phenomena in the same person (due to genetic or environmental influences), secondary to endocrine disease complications or effects of advanced glycation end products in the case of diabetes. Rheumatic manifestations of diabetes, thyroid, pituitary, parathyroid, and adrenal disorders will be discussed.

Rheumatic diseases are associated with endocrine disorders which may have an impact on the clinical aspects of those diseases. The impact of endocrine disorders on rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and Sjögren’s syndrome (SS) is reviewed. Rheumatoid arthritis is the most common coexisting autoimmune disorder in patients with Grave’s disease and Hashimoto thyroiditis. RA patients are more likely to have thyroid-related antibodies, and some studies indicate an increased prevalence of thyroid diseases in RA. Hypothyroidism contributes to the increased risk for cardiovascular diseases and metabolic syndrome in RA patients and may be correlated with RA disease activity and response to treatment. In most studies, thyroid diseases (mainly hypothyroidism) are more common in SLE patients. Their impact on disease activity is controversial. Pregnant SLE patients are more prone to develop thyroid diseases and pospartum thyroitidis, and in case they suffer from thyroid disease, they have an increased prevalence of preterm delivery. Polyautoimmunity is reported in a high percentage of SS patients. The most frequent coexisting disease is autoimmune thyroid disease (AITD) which may be partially explained by the higher prevalence of thyroid dysfunction in middle-aged women rather than a true association. The prevalence of SS among patients with autoimmune thyroiditis is increased by two- to tenfold.

Patients with RA have an increased risk of insulin resistance (IR) and diabetes (DM) secondary to genetic, inflammatory components or to comorbidities and treatment. The impact of diabetes on disease activity is yet to be fully elucidated. Some of the therapies for RA have a positive impact on DM. Although poly-autoimmunity is frequently described in SLE, the association with type 1 DM is uncommon. An association between SLE and insulin resistance and DM type II is described. Glucocorticoids might have an impact on development of DM, while hydroxycholoroquine treatment is protective. DM does not appear to be a major contributor to damage accrual in SLE.

Addison’s disease is mainly related to endocrine autoimmunities, and the association with connective tissue diseases is rare. Cushing syndrome in the rheumatic diseases is mainly secondary to glucocorticoid treatment.

Prolactinoma is associated with an increased risk for autoimmune diseases. Autoimmune thyroid disease is the most common, while rheumatic diseases are rare. Data concerning prolactin and RA are conflicting. Hyperprolactinemia has been described in 20–30% of patients with SLE, but the exact origin of the increased prolactin in SLE patients is unknown. Prolactin might be an independent factor related to SLE activity and disease damage. Elevated prolactin during pregnancy in SLE patients is associated with lupus activity and poor outcome. Bromocriptine (a dopaminergic drug) reduced SLE flares in non-pregnant patients and prevented flares and improved fetal and maternal outcome during pregnancy.

Clinical bone disease secondary to primary hyperparathyroidism is rare today thanks to early detection. Chondrocalcinosis may appear in hyperparathyroid patients. Hyperparathyroidism is probably not increased in RA and SLE.

The association between hypoparathyroidism and rheumatoid arthritis is rare. Hypoparathyroidism was found to be increased in SLE patients and may be secondary to anti-parathyroid antibodies.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 279.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 379.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Abd-Elnabi H, El-Gamasy M, Abd-Elhafez M. Thyroid dysfunctions in a sample of Egyptian children and adolescents with SLE: relation to disease activity and duration. Egypt J Immunol. 2016;23(2):65–73.

    Google Scholar 

  • Al Saleh J, Sayed M, Jassim V, Mohammed N, Khan N. Hypothyroidism determines the clinical and immunological manifestations of Arabs with lupus. Lupus. 2008;17(3):215–20.

    Article  Google Scholar 

  • Albrecht K, Luque Ramos A, Hoffmann F, Redeker I, Zink A. High prevalence of diabetes in patients with rheumatoid arthritis: results from a questionnaire survey linked to claims data. Rheumatology. 2018;57(2):329–36. https://doi.org/10.1093/rheumatology/kex414.

    Article  Google Scholar 

  • Aloush V, Litinsky I, Caspi D, Elkayam O. Propylthiouraci induced autoimmune syndromes: two distinct clinical presentations with different course and management. Semin Arthritis Rheum. 2006;36:4–9.

    Article  CAS  Google Scholar 

  • Alvarez-Nemegyei J, Cobarrubias-Cobos A, Escalante-Triay F, Sosa-Muüoz J, Miranda JM, Jara LJ. Bromocriptine in systemic lupus erythematosus: a double-blind, randomized, placebo-controlled study. Lupus. 1998;7(6):414–9.

    Article  CAS  Google Scholar 

  • Anaya JM, Rojas-Villarraga A, Mantilla RD, Arcos-Burgos M, Sarmiento-Monroy JC. Polyautoimmunity in Sjögren syndrome. Rheum Dis Clin N Am. 2016;42:457–72.

    Article  Google Scholar 

  • Antohe J l, Bili A, Sartorius JA, Kirchner HL, Morris SJ, Dancea S, Wasko MCM. Diabetes mellitus risk in rheumatoid arthritis: reduced incidence with anti-tumor necrosis factor α therapy. Arthritis Care Res. 2012;64(2):215–21. https://doi.org/10.1002/acr.20657.

    Article  CAS  Google Scholar 

  • Antonelli A, Fallahi P, Mosca M, Ferrari SM, Ruffilli I, Corti A, … Bombardieri S. Prevalence of thyroid dysfunction in SLE. Metabolism. 2010;59:896–900.

    Google Scholar 

  • Balavoine AS, Glinoer D, Dubucquoi S, Wémeau JL. Antineutrophil cytoplasmic antibody-positive small-vessel vasculitis associated with antithyroid drug therapy: how significant is the clinical problem? Thyroid. 2015;25(12):1273–81.

    Article  CAS  Google Scholar 

  • Banon S, Isenberg DA. Rheumatological manifestations occurring in patients with diabetes mellitus. Scand J Rheumatol. 2013;42:1–10.

    Article  CAS  Google Scholar 

  • Bengtsson C, Padyukov L, Kallberg H, Saevarsdottir S. Thyroxin substitution and the risk of developing rheumatoid arthritis: results from the Swedish population based EIRA study. Ann Rheum Dis. 2014;73:1096–100.

    Article  CAS  Google Scholar 

  • Bilge SY, Korkmaz C. Calcium metabolism disorders simulating rheumatologic diseases. Rheumatol Int. 2012;32:1503–5.

    Article  Google Scholar 

  • Boelaert K, Newby PR, Simmonds MJ, Holder RL, Carr-Smith JD, Heward JM, … Lazarus JH. Prevalence and relative risk of the autoimmune diseases in subjects with autoimmune thyroid disease. Am J Med. 2010;123(2):e1–183.

    Google Scholar 

  • Boswell SB, Patel DB, White EA, Gottsegen CJ, Forrester DM, Masih S, Matcuk GR. Musculoskeletal manifestations of endocrine disorders. Clin Imaging. 2014;38:384–96.

    Article  Google Scholar 

  • Bouchard B, Ormandy CJ, Di Santo JP, Kelly PA. Immune system development and function in prolactin receptor-deficient mice. J Immunol. 1999;163(2):576–82.

    Google Scholar 

  • Bruce IN, Urowitz MB, Gladman D, Bañez D, Steiner G. Risk factors for coronary heart disease in women with SLE arthritis and rheumatism. Arthritis Rheum. 2003;48(11):3159–67.

    Article  Google Scholar 

  • Caramaschi P, Biasi D, Caimmi C, Scambi C, Pieropan S, Barausse G, Adami S. The co-occurrence of Hashimoto thyroiditis in primary Sjogren’s syndrome defines a subset of patients with milder clinical phenotype. Rheumatol Int. 2013;33(5):1271–5. https://doi.org/10.1007/s00296-012-2570-6.

    Article  CAS  Google Scholar 

  • Chakravarty SD, Markenson JA. Rheumatic manifestations of endocrine disease. Curr Opin Rheumatol. 2013;25(1):37–43. https://doi.org/10.1097/BOR.0b013e32835b4f3f.

    Article  CAS  Google Scholar 

  • Charles PJ, Plant D, Chowdhury M, Worthington J, Venables P. Antibodies to thyroglobulin and thyroperoxidase in rheumatoid arthritis: environmental and genetic associations. Ann Rheum Dis. 2011;70(Suppl 2):A88–9.

    Article  Google Scholar 

  • Chen LH, Li CY, Kuo LC, Wang LY, Kuo KN, Jou IM, Hou WH. Risk of hand syndromes in patients with diabetes mellitus. Medicine. 2015a;94(41):e1575.

    Article  Google Scholar 

  • Chen YM, Lin CH, Lan TH, Chen HH, Chang SN, Chen YH, … Chen DY. Hydroxycholoroquine reduces risk of incident diabetes mellitus in lupus patients in a dose dependent manner: a population-based cohort study. Rheumatology. 2015b;54:1244–9.

    Google Scholar 

  • Chen HH, Chen DY, Lin CC, Chen YM, Lai KL, Lin CH. Association between use of disease modifying antirheumatic drugs and diabetes in patients with ankylosing spondylitis, RA and psoriasis \ PSA: a nationwide population-based cohort study. Ther Clin Risk Manag. 2017;13:583–92.

    Article  CAS  Google Scholar 

  • Chung CP, Oeser A, Solus JF, Avalos I, Gebretsadik T, Shintani A, … Stein CM. Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis. Atherosclerosis. 2008;196(2):756–63. Retrieved from https://www.sciencedirect.com/science/article/pii/S0021915007000457

  • Cortes S, Chambers S, Jerónimo A, Isenberg D. Diabetes mellitus complicating systemic lupus erythematosus-analysis of the UCL lupus cohort and review of the literature. Lupus. 2008;17:977–80.

    Article  CAS  Google Scholar 

  • Costanza M, Binart N, Steinman L, Pedotti R. Prolactin: a versatile regulator of inflammation and autoimmune pathology. Autoimmun Rev. 2015;14(3):223–30.

    Article  CAS  Google Scholar 

  • Courties A, Sellam J. Osteoarthritis and type 2 diabetes mellitus: what are the links? Diabetes Res Clin Pract. 2016;122:198. Retrieved from https://www.sciencedirect.com/science/article/pii/S0168822716308701

    Article  CAS  Google Scholar 

  • Crepaldi G, Scirè CA, Carrara G, Sakellariou G, Caporali R, Hmamouchi I, … Montecucco C. Cardiovascular comorbidities relate more than others with disease activity in rheumatoid arthritis. PLoS One. 2016;11(1):e0146991. https://doi.org/10.1371/journal.pone.0146991.

  • den Uyl D, van Raalte DH, Nurmohamed MT, Lems WF, Bijlsma JWJ, Hoes JN, … Diamant M. Metabolic effects of high-dose prednisolone treatment in early rheumatoid arthritis: balance between diabetogenic effects and inflammation reduction. Arthritis Rheum. 2012;64(3):639–46. https://doi.org/10.1002/art.33378.

  • Dougados M, Soubrier M, Antunez A, Balint P, Balsa A, Buch MH, … Kay J. Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA). Ann Rheum Dis. 2014;73(1):62–8. https://doi.org/10.1136/annrheumdis-2013-204223.

  • Dowart BB, Schumacher HR. Joint effusions and chodrocalcinosis in hypothyroidism. Arthritis Rheum. 1975;18(5):529.

    Google Scholar 

  • El Miedany YM, Ahmed I, Moustafa H, El Baddini M. Hyperprolactinemia in Sjögren syndrome: a patient subset or a disease manifestation? Joint Bone Spine. 2004;71(3):203–8.

    Article  Google Scholar 

  • Elfving P, Puolakka K, Kautiainen H, Virta LJ, Pohjolainen T, Kaipiainen-Seppänen O. Drugs used in incident systemic lupus erythematosus–results from the Finnish nationwide register 2000–2007. Lupus. 2016;25(6):666–70.

    Article  CAS  Google Scholar 

  • Elnady BM, Kamal NM, Shaker RH, Soliman AF, Hasan WA, Alghamdi HA, … Jajah MB. Prevalence and clinical significance of non-organ specific antibodies in patients with autoimmune thyroiditis as predictor markers for rheumatic diseases. Medicine. 2016;95(38):e4336.

    Google Scholar 

  • Emamifar A, Hangaard J, Hansen IM. Thyroid disorders in patients with newly diagnosed rheumatoid arthritis is associated with poor initial treatment response evaluated by disease activity score in 28 joint C- reactive protein (DAS-28 CRP). Medicine. 2017;96(43):e8357.

    Article  Google Scholar 

  • Fallahi P, Ferrari SM, Ruffilli I, Elia G, Biricotti M, Vita R, … Antonelli A. The association of other autoimmune diseases in patients with autoimmune thyroiditis: review of the literature and report of a large series of patients. Autoimmun Rev. 2016;15(12):1125–8.

    Google Scholar 

  • Gamstedt A, Holm-Glad J, Ohlson CG, Sundström M. Hand abnormalities are strongly associated with the duration of diabetes mellitus. J Intern Med. 1993;234(2):189–93.

    Article  CAS  Google Scholar 

  • Gao H, Li C, Mu R, Guo YQ, Liu T, Chen S, … Li ZG. Subclinical hypothyroidism and its association with lupus nephritis: a case control study in a large cohort of Chinese systemic lupus erythematosus patients. Lupus. 2011;20(10):1035–41.

    Google Scholar 

  • Gerrits EG, Landman GW, Bilo HJ, Nijenhuis-Rosien L. Limited joint mobility syndrome in diabetes mellitus: a mini review. World J Diabetes. 2015;6(9):1108–12.

    Article  Google Scholar 

  • Gherghe AM, Dougados M, Combe B, Landewé R, Mihai C, Berenbaum F, … van der Heijde D. Cardiovascular and selected comorbidities in early arthritis and early spondyloarthritis, a comparative study: results from the ESPOIR and DESIR cohorts. RMD Open. 2015;1(1):e000128. https://doi.org/10.1136/rmdopen-2015-000128.

  • Ha YJ, Lee KH, Jung SJ, Lee SW, Lee SK, Park YB. Glucocorticoid induced diabetes mellitus in patients with SLE treated with high dose glucocorticoid therapy. Lupus. 2011;20(10):1027–34.

    Article  CAS  Google Scholar 

  • Hage MP, Al-Badri MR, Azar ST. A favorable effect of hydroxychloroquine on glucose and lipid metabolism beyond its anti-inflammatory role. Ther Adv Endocrinol Metab. 2014;5(4):77–85.

    Article  CAS  Google Scholar 

  • Hansen BU, Ericsson UB, Henricsson V, Larsson A, Manthorpe R, Warfvinge G. Autoimmune thyroiditis and primary Sjögren’s syndrome: clinical and laboratory evidence of the coexistence of the two diseases. Clin Exp Rheumatol. 1991;9(2):137–41. Retrieved from https://europepmc.org/abstract/med/2060160

    CAS  Google Scholar 

  • Hochberg MC, Silman AJ, Smolen JS, Weisman M, Weinblatt M. Rheumatology, vol. 2. 6th ed. Philadelphia: Mosby-Elsevier; 2015.

    Google Scholar 

  • Innala L, Sjoberg C, Moller B, Ljung L, Smedby T, Södergren A, … Wållberg-Jonsson S. Co-morbidity in patients with early rheumatoid arthritis-inflammation matters. Arthritis Res Ther. 2016;18(1):33.

    Google Scholar 

  • Jacobi AM, Rohde W, Ventz M, Riemekasten G, Burmester GR, Hiepe F. Enhanced serum prolactin (PRL) in patients with systemic lupus erythematosus: PRL levels are related to the disease activity. Lupus. 2001;10(8):554–61.

    Article  CAS  Google Scholar 

  • Jafri K, Bartels CM, Shin D, Gelfand JM, Ogdie A. Incidence and management of cardiovascular risk factors in psoriatic arthritis and rheumatoid arthritis: a population-based study. Arthritis Care Res. 2017;69(1):51–7. https://doi.org/10.1002/acr.23094.

    Article  Google Scholar 

  • Jara L, Cruz-Cruz P, Saavedra M, Medina G, García-Flores A, Angeles U, Miranda-Limón J. Bromocriptine during pregnancy in SLE. A pilot clinical trial. Ann N Y Acad Sci. 2007a;1110(1):297–304.

    Article  CAS  Google Scholar 

  • Jara LJ, Pacheco-Reyes H, Medina G, Angeles U, Cruz-Cruz P, Saavedra MA. Prolactin levels are associated with lupus activity, lupus anticoagulant, and poor outcome in pregnancy. Ann N Y Acad Sci. 2007b;1108(1):218–26.

    Article  CAS  Google Scholar 

  • Jara LJ, Medina G, Saavedra MA, Jara LJ, Medina G, Saavedra MA, … Espinoza LR. Prolactin had a pathogenic role in systemic lupus erythematosis. Immunol Res. 2017;65:512–3.

    Google Scholar 

  • Jiang P, Li H, Li X. Diabetes mellitus risk factors in rheumatoid arthritis: a systematic review and meta-analysis. Clin Exp Rheumatol. 2015;33(1):115–21. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/25535750

    Google Scholar 

  • Joshi P, Agarwal A, Vyas S, Kumar R. Prevalence of hypothyroidism in rheumatoid arthritis and its correlation with disease activity. Trop Doct. 2017;47(1):6–10.

    Article  Google Scholar 

  • Kaklamanos M, Thomas D, Pikazis D, Kaltsas G. Thyroid specific changes flowing treatment with biological therapies in patients with rheumatic diseases. Endocrine. 2015;50(1):146–53.

    Article  CAS  Google Scholar 

  • Kiss C, Szilagyi M, Paksy A, Poor G. Risk factors for diffuse idiopathic skeletal hyperostosis: a case-control study. Rheumatology. 2002;41:27–30.

    Article  CAS  Google Scholar 

  • Köller M, Tempel E, Riedl M, Clodi M, Wagner O, Smolen JS, Luger A. Pituitary function in patients with newly diagnosed untreated systemic lupus erythematosus. Ann Rheum Dis. 2004;63(12):1677–80.

    Article  Google Scholar 

  • Koszarny A, Majdan M, Suszek D, Wielosz E, Dryglewska M. Relationship between rheumatoid arthritis activity and anti thyroid antibodies. Pol Arch Intern Med. 2013;123(7–8):394–400.

    Article  CAS  Google Scholar 

  • Kota SK, Meher LK, Jammula S, Kota SK, Modi KD. Clinical profile of coexisting conditions in type 1 diabetes mellitus patients. Diabetes Metab Syndr Clin Res Rev. 2012;6(2):70–6.

    Article  Google Scholar 

  • Kramer CK, Tourinho TF, de Castro WP, da Costa Oliveira M. Association between systemic lupus erythematosus, rheumatoid arthritis, hyperprolactinemia and thyroid autoantibodies. Arch Med Res. 2005;36(1):54–8.

    Article  CAS  Google Scholar 

  • Kuo CF, Grainge MJ, Valdes AM, See LC, Luo SF, Yu KH, … Doherty M. Familial aggregation of SLE and coaggregation of autoimmune diseases in affected families. JAMA Intern Med. 2015;175(9):1518–26.

    Google Scholar 

  • Kuo C-F, Grainge MJ, Valdes AM, See L-C, Yu K-H, Shaw SWS, … Doherty M. Familial aggregation of rheumatoid arthritis and co-aggregation of autoimmune diseases in affected families: a nationwide population-based study. Rheumatology. 2017;56(6):928–33. https://doi.org/10.1093/rheumatology/kew500.

  • Larouche V, Correa JA, Cassidy P, Beauregard C, Garfield N, Rivera J. Prevalence of autoimmune disease in patients with prolactinomas and non-functioning pituitary adenoma. Pituitary. 2016;19(2):202–9.

    Article  CAS  Google Scholar 

  • Lazurova I, Benhatchi K, Rovensky J, Kozáková D, Wagnerová H, Tajtáková M, … Macejova Z. Autoimmune thyroid diseases and autoimmune rheumatic disorders: a two sided analysis. Ann N Y Acad Sci. 2009;1173(1):211–6.

    Google Scholar 

  • Lazúrová I, Jochmanová I, Benhatchi K, Sotak Š. Autoimmune thyroid disease and rheumatoid arthritis: relationship and the role of genetics. Immunol Res. 2014;60(2–3):193–200.

    Article  CAS  Google Scholar 

  • Lee YH, Bae SC, Song GG. Meta-analysis of associations between functional prolactin-1149 G/T polymorphism and susceptibility to rheumatoid arthritis and systemic lupus erythematosus. Clin Rheumatol. 2015;34(4):683–90.

    Article  Google Scholar 

  • LeRiche NG, Bell DA. Hashimoto thyroiditis and polyarthritis: a possible subset of seronegative polyarthritis. Ann Rheum Dis. 1984;43:594–8.

    Article  CAS  Google Scholar 

  • Liao KP, Gunnarsson M, Källberg H, Ding B, Plenge RM, Padyukov L, … Alfredsson L. Specific association of type 1 diabetes mellitus with anti-cyclic citrullinated peptide-positive rheumatoid arthritis. Arthritis Rheum. 2009;60(3):653–60. https://doi.org/10.1002/art.24362.

  • Lin W, Chang CL, Fu LS, Lin CH, Lin HK. Systemic lupus erythematosus and thyroid disease: a 10-year study. J Microbiol Immunol Infect. 2015;48:676–83.

    Article  Google Scholar 

  • Lu M-C, Yin W-Y, Tsai T-Y, Koo M, Lai N-S. Increased risk of primary Sjögren’s syndrome in female patients with thyroid disorders: a longitudinal population-based study in Taiwan. PLoS One. 2013;8(10):e77210. https://doi.org/10.1371/journal.pone.0077210.

    Article  CAS  Google Scholar 

  • Lu M-C, Yan S-T, Yin W-Y, Koo M, Lai N-S. Risk of rheumatoid arthritis in patients with type 2 diabetes: a nationwide population-based case-control study. PLoS One. 2014;9(7):e101528. https://doi.org/10.1371/journal.pone.0101528.

    Article  CAS  Google Scholar 

  • Mader R, Mishail S, Adawi M, Lavi I, Luboshitzky R. Thyroid dysfunction in patients with systemic lupus erythematosus (SLE): relation to disease activity. Clin Rheumatol. 2007;26(11):1891–4.

    Article  Google Scholar 

  • Mavragani C, Fragoulis G, Moutsopoulos H. Endocrine alternations in primary Sjögren’s syndrome: an overview. J Autoimmun. 2012;39:354–8.

    Article  CAS  Google Scholar 

  • McCoy SS, Crowson CS, Gabriel SE, Matteson EL. Hypothyroidism as a risk factor for development of cardiovascular disease in patients with rheumatoid arthritis. J Rheumatol. 2012;39(5):954–8.

    Article  Google Scholar 

  • McMurray RW, Weidensaul D, Allen SH, Walker SE, et al. Efficacy of bromocriptine in an open label therapeutic trial for systemic lupus erythematosus. J Rheumatol. 1995;22(11):2084–91.

    CAS  Google Scholar 

  • Merashli M, Chowdhury TA, Jawad ASM. Musculoskeletal manifestations of diabetes mellitus. Int J Med. 2015;108(11):853–7.

    CAS  Google Scholar 

  • Miller FW, Moore GF, Weintraub BD, Steinberg AD. Prevalence of thyroid disease and abnormal thyroid function test results in patients with systemic lupus erythematosus. Arthritis Rheum. 1987;30(10):1124–31.

    Article  CAS  Google Scholar 

  • Miyake CN, Gualano B, Dantas WS, Pereira RT, Neves W, Zambelli VO, … Borba E. Increased insulin resistance and glucagon levels in mild\inactive systemic lupus patients despite normal glucose tolerance. Arthritis Care Res. 2017. https://doi.org/10.1002/acr.23237.

  • Morita S, Arima T, Matsuda M. Prevalence of non-thyroid specific autoantibodies in autoimmune thyroid diseases. J Clin Endocrinol Metabol. 1995;80(4):1203–6.

    CAS  Google Scholar 

  • Movahedi M, Beauchamp M-E, Abrahamowicz M, Ray DW, Michaud K, Pedro S, Dixon WG. Risk of incident diabetes associated with dose and duration of oral glucocorticoid therapy in patients with rheumatoid arthritis. Arthritis Rheumatol. 2015;68(5):1089–98. https://doi.org/10.1002/art.39537.

    Article  CAS  Google Scholar 

  • Nicolau J, Lequerré T, Bacquet H, Vittecoq O. Rheumatoid arthritis, insulin resistance, and diabetes. Joint Bone Spine. 2017;84(4):411–6. Retrieved from https://www.sciencedirect.com/science/article/pii/S1297319X16301531

    Article  CAS  Google Scholar 

  • Notsu K, Note S, Nabeya N. Antinuclear antibodies in childhood diabetes. Endocrinol Japon. 1983;30(4):469–73.

    Article  CAS  Google Scholar 

  • Ogata A, Morishima A, Hirano T, Hishitani Y, Hagihara K, Shima Y, … Tanaka T. Improvement of HbA1c during treatment with humanised anti-interleukin 6 receptor antibody, tocilizumab. Ann Rheum Dis. 2011;70(6):1164–5. https://doi.org/10.1136/ard.2010.132845.

  • Örük G, Tarhan F, Argın M, Özmen M. Is every joint symptom related to acromegaly? Endocrine. 2013;43(2):404–11.

    Article  CAS  Google Scholar 

  • Ozen G, Pedro S, Holmqvist ME, Avery M, Wolfe F, Michaud K. Risk of diabetes mellitus associated with disease-modifying antirheumatic drugs and statins in rheumatoid arthritis. Ann Rheum Dis. 2017;76(5):848–54. https://doi.org/10.1136/ANNRHEUMDIS-2016-209954.

    Article  Google Scholar 

  • Pan XP, Gu JQ, Shan ZY. Increased risk of thyroid autoimmunity in rheumatoid arthritis: a systematic review and meta-analysis. Endocrine. 2015;50:79–86.

    Article  CAS  Google Scholar 

  • Parker B, Urowitz MB, Gladman DD, Lunt M, Bae SC, Sanchez-Guerrero J, … Bernatsky S. Clinical associations of the metabolic syndrome in SLE: data form an international inception cohort. Ann Rheum Dis. 2013;72(8):1308–14.

    Google Scholar 

  • Penn SK, Kao AH, Schott LL, Elliott JR, Toledo FG, Kuller L, … Wasko MC. Hydroxychloroquine and glycemia in women with rheumatoid arthritis and systemic lupus erythematosus. J Rheumatol. 2010;37(6):1136–42.

    Google Scholar 

  • Petri M, Purvey S, Fang H. Predictors of organ damage in SLE: the Hopkins lupus cohort. Arthritis Rheum. 2012;64(12):4021–8.

    Article  CAS  Google Scholar 

  • Podgorski M, Robinson B, Weissberger A, Stiel J, Wang S, Brooks PM. Articular manifestations of acromegaly. Aust NZ J Med. 1988;18(1):28–35.

    Article  CAS  Google Scholar 

  • Pourmemari MH, Shiri R. Diabetes as a risk factor for carpal tunnel syndrome: a systematic review and meta-analysis. Diabet Med. 2016;33(1):10–6.

    Article  CAS  Google Scholar 

  • Proto RF, Proietta M, Koverech A. Hypercalcemia in systemic lupus erythematosis. Lupus. 2011;20:758–62.

    Article  Google Scholar 

  • Punzi L, Michelotto M, Pianon M, Bertazzolo N, Fagiolo U, Betterle C, … Todesco S. Clinical laboratory and immunogenetic aspects of arthritis associated with chronic lymphocytic thyroiditis. Clin Exp Rheumatol. 1997;15(4):373–80.

    Google Scholar 

  • Pyne D, Isenberg DA. Autoimmune thyroid disease in SLE. Ann Rheum Dis. 2002;61(1):70–2.

    Article  CAS  Google Scholar 

  • Ralston SH, Frases WD, Jankowski J. Hypercalemia in Rheuamtoid arthritis revisited. Ann Rheum Dis. 1990;49:22–4.

    Article  CAS  Google Scholar 

  • Ramos-Casals M, García-Carrasco M, Cervera R. Thyroid disease in primary Sjögren syndrome. Study in a series of 160 patients. Medicine. 2000;79(2):103–8. Retrieved from https://europepmc.org/abstract/med/10771708

    Article  CAS  Google Scholar 

  • Rasmussen UF. Increased risk of thyroid autoimmunity in rheumatoid arthritis. Endocrine. 2015;50:4–5.

    Article  CAS  Google Scholar 

  • Raterman HG, Nurmohamed MT. Hypothyroidism in rheumatoid arthritis-to screen or not to screen. J Rheumatol. 2012;399:885–6.

    Article  Google Scholar 

  • Raterman HG, Van Halm VP, Voskuyl AE, Simsek S, Dijkmans BAC, Nurmohamed MT. Rheumatoid arthritis is associated with a high prevalence of hypothyroidism that amplifies its cardiovascular risk. Ann Rheum Dis. 2008;67(2):229–32.

    Article  CAS  Google Scholar 

  • Raterman HG, Van Eijk IC, Voskuyl AE, Peters MJL, Dijkmans BAC, Van Halm VP, … Nurmohamed MT. The metabolic syndrome is amplified in hypothyroid rheumatoid arthritis patients: a cross sectional study. Ann Rheum Dis. 2010;69:39–42.

    Google Scholar 

  • Raterman HG, Jamnitski A, Lems WF, Voskuyl AE, Dijkmans BA, Bos WH, … de Koning MH, Nurmohamed MT. Improvement of thyroid function in hypothyroid patients with rheumatoid arthritis after 6 months of adalimumab treatment: a pilot study. J Rheumatol. 2011;38(2):247–51.

    Google Scholar 

  • Rempenault C, Combe B, Barnetche T, Gaujoux-Viala C, Lukas C, Morel J, Hua C. Metabolic and cardiovascular benefits of hydroxychloroquine in patients with rheumatoid arthritis: a systematic review and meta-analysis. Ann Rheum Dis. 2018;77(1):98–103. https://doi.org/10.1136/ANNRHEUMDIS-2017-211836.

    Article  CAS  Google Scholar 

  • Rojas-Villarraga A, Toro CE, Espinosa G. Factors influencing polautommmunity in SLE. Autoimmun Rev. 2010;9:229–32.

    Article  CAS  Google Scholar 

  • Ruiz-Arruza I, Ugarte A, Cabezas-Rodriguez I, Medina JA, Moran MA, Ruiz-Irastorza G. Glucocorticoids and irreversible damage in patients with systemic lupus erythematosus. Rheumatology. 2014;53(8):1470–6.

    Article  CAS  Google Scholar 

  • Ruscitti P, Ursini F, Cipriani P, Ciccia F, Liakouli V, Carubbi F, … Giacomelli R. Prevalence of type 2 diabetes and impaired fasting glucose in patients affected by rheumatoid arthritis: results from a cross-sectional study. Medicine. 2017a;96(34):e7896. https://doi.org/10.1097/MD.0000000000007896.

  • Ruscitti P, Ursini F, Cipriani P, Liakouli V, Carubbi F, Berardicurti O, … Giacomelli R. Poor clinical response in rheumatoid arthritis is the main risk factor for diabetes development in the short-term: a 1-year, single-centre, longitudinal study. PLoS One. 2017b;12(7):e0181203. https://doi.org/10.1371/journal.pone.0181203.

  • Senanayake HMS, Dedigama AD, De Alwis RP, Thirumavalavan K. Hoffmann syndrome: a case report. Int Arch Med. 2014;7(1):2.

    Article  Google Scholar 

  • Sencan D, Elden H, Nacitarhan V, Sencan M, Kaptanoglu E. The prevalence of diffuse idiopathic skeletal hyperostosis in patients with diabetes mellitus. Rheumatol Int. 2005;25(7):518–21. https://doi.org/10.1007/s00296-004-0474-9.

    Article  CAS  Google Scholar 

  • Shahin D, Eltoraby E, Mesbah A, Houssen M. Insulin resistance in early untreated rheumatoid arthritis patients. Clin Biochem. 2010;43(7–8):661–5. Retrieved from https://www.sciencedirect.com/science/article/pii/S000991201000055X

    Article  CAS  Google Scholar 

  • Shimizu M, Kawata M, Okada T, Yuu H, Kurahashi T, Yamanaka K, Umezu K. Concomitant Cushing’s syndrome due to adrenal adenoma in a patient with systemic lupus erythematosus. Intern Med. 2002;41(11):1044–6.

    Article  Google Scholar 

  • Shiroky JB, Cohen M, Ballachey ML, Neville C. Thyroid dysfunction in rheumatoid arthritis: a controlled prospective survey. Ann Rheum Dis. 1993;52(6):454–6.

    Article  CAS  Google Scholar 

  • Siebert S, Lyall DM, Mackay DF, Porter D, McInnes IB, Sattar N, Pell JP. Characteristics of rheumatoid arthritis and its association with major comorbid conditions: cross-sectional study of 502 649 UK biobank participants. RMD Open. 2016;2(1):e000267. https://doi.org/10.1136/rmdopen-2016-000267.

    Article  Google Scholar 

  • Simard JF, Mittleman MA. Prevalent rheumatoid arthritis and diabetes among NHANES III participants aged 60 and older. J Rheumatol. 2007;34(3):469–73. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/17183622

    Google Scholar 

  • Solomon DH, Massarotti E, Garg R, Liu J, Canning C, Schneeweiss S. Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis. JAMA. 2011;305(24):2525. https://doi.org/10.1001/jama.2011.878.

    Article  CAS  Google Scholar 

  • Stagnaro-Green A, Akhter E, Yim C, Davies TF, Magder LS, Petri M. Thyroid disease in pregnant women with SLE: increase preterm delivery. Lupus. 2011;20(7):690–9.

    Article  CAS  Google Scholar 

  • Tagoe CE, Zezon A, Khattri S. Rheumatic manifestations of autoimmune thyroid disease: the other autoimmune disease. J Rheumatol. 2012;39(6):1125–9.

    Article  CAS  Google Scholar 

  • Takaya K, Kimura N, Hiyoshi T. Antithyroid arthritis syndrome: report and review of the literature. Intern Med. 2016;55(24):3627–33.

    Article  Google Scholar 

  • Tang MW, Garcia S, Gerlag DM, Tak PP, Reedquist KA. Insight into the endocrine system and the immune system: of the inflammatory role of prolactin in rheumatoid arthritis and psoriatic arthritis. Front Immunol. 2017;8:720.

    Article  CAS  Google Scholar 

  • Tektonidou MG, Anapliotou M, Vlachoyiannopoulos P, Moutsopoulos HM. Presence of systemic autoimmune disorders in patients with autoimmune thyroid diseases. Ann Rheum Dis. 2004;63(9):1159–61. Retrieved from http://ard.bmj.com/content/63/9/1159.short

    Article  CAS  Google Scholar 

  • Ugarte-Gil MF, Gamboa-Cárdenas R, Zevallos F, Medina M, Cucho-Venegas JM, Perich-Campos RA, Alfaro-Lozano JL, … Pastor-Asurza CA. High prolactin levels are independently associated with damage accrual in SLE patients. Lupus. 2014;23(10):969–74.

    Google Scholar 

  • Ulff-Møller CJ, Simonsen J, Kyvik KO, Jacobsen S, Frisch M. Family history of SLE and risk of autoimmune disease: nationwide cohort study in Denmark 1977–2013. Rheumatology. 2017;56:957–64.

    Article  Google Scholar 

  • Urowitz MB, Gladman D, Ibanez D, Fortin P, Sanchez-Guerrero J, Bae S, … Wallace D. Clinical manifestations and coronary artery risk factors at diagnosis of SLE: data form an international inception cohort. Lupus. 2007;16(9):731–5.

    Google Scholar 

  • Urowitz MB, Gladman D, Ibañez D. Atherosclerosis vascular events in multinational inception cohort of SLE. Arthritis Care Res. 2010;62(6):881–7.

    Article  CAS  Google Scholar 

  • Urowitz MB, Gladman DD, Anderson NM, Su J, Romero-Diaz J, Bae SC, … Gordon C. Cardiovascular events prior to or early after diagnosis of systemic lupus erythematosus in the systemic lupus international collaborating clinics cohort. Lupus Sci Med. 2016;3(1):e000143.

    Google Scholar 

  • Ursini F, Russo E, D’Angelo S, Arturi F, Hribal ML, D’Antona L, … Grembiale RD. Prevalence of undiagnosed diabetes in rheumatoid arthritis: an OGTT study. Medicine. 2016;95(7):e2552. https://doi.org/10.1097/MD.0000000000002552.

  • Uthman I, Senécal JL. Onset of rheumatoid arthritis after surgical treatment of Cushings disease. J Rheumotol. 1995;22(10):1964–6.

    CAS  Google Scholar 

  • Vera-Lastra O, Mendez C, Jara LJ, Cisneros M, Medina G, Ariza R, Espinoza LR. Correlation of prolactin serum concentrations with clinical activity and remission in patients with systemic lupus erythematosus. Effect of conventional treatment. J Rheumatol. 2003;30(10):2140–6.

    CAS  Google Scholar 

  • Walker SE. Bromocriptine treatment of systemic lupus erythematosus. Lupus. 2001;10(10):762–8.

    Article  CAS  Google Scholar 

  • Wallace DJ, Hahn BH. Dubois’ lupus erythematosus. 7th edition, 2006.

    Google Scholar 

  • Wang X, Bao W, Liu J, Ouyang Y-Y, Wang D, Rong S, … Liu L-G. Inflammatory markers and risk of type 2 diabetes: a systematic review and meta-analysis. Diabetes Care. 2013;36(1):166–75. https://doi.org/10.2337/dc12-0702.

  • Wasko MCM, Hubert HB, Lingala VB, Elliott JR, Luggen ME, Fries JF, Ward MM. Hydroxychloroquine and risk of diabetes in patients with rheumatoid arthritis. JAMA. 2007;298(2):187. https://doi.org/10.1001/jama.298.2.187.

    Article  CAS  Google Scholar 

  • Wen HY, Schumacher HJ, Zhang LY. Parathyroid disease. Rheum Dis Clin N Am. 2010;36(4):647–64.

    Article  Google Scholar 

  • Yakushiji F, Kita M, Hiroi N, Ueshiba H, Monma I, Miyachi Y. Exacerbation of rheumatoid arthritis after removal of adrenal adenoma in Cushing’s syndrome. Endocr J. 1995;42(2):219–23.

    Article  CAS  Google Scholar 

  • Zelissen PMJ, Bast E, Croughs RJM. Associated autoimmunity in Addison’s disease. J Autoimmun. 1995;8(1):121–30.

    Article  CAS  Google Scholar 

  • Zhang ZI, Wang Y, Zhou W, Hao YJ. Addison’s disease secondary to connective tissue disease: a report of six cases. Rheumatol Int. 2009;29(6):647–50.

    Article  Google Scholar 

  • Zonana-Nacach A, Barr SG, Magder LS, Petri M. Damage in SLE and its association with corticosteroids. Arthritis Rheum. 2000;43(8):1801–8.

    Article  CAS  Google Scholar 

  • Zriek NH, Malik RA, Charalambous PC. Adhesive capsulitis of the shoulder and diabetes: a meta-analysis of prevalence. Muscle Ligaments Tendons J. 2016;6(1):26–34.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Rheumatology Unit, Department of Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel

    Hagit Peleg & Eldad Ben-Chetrit

Authors
  1. Hagit Peleg
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eldad Ben-Chetrit
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hagit Peleg .

Editor information

Editors and Affiliations

  1. Department of Biomedical Sciences and Human Oncology, University of Bari “Aldo Moro”, Clinica Medica “Augusto Murri”, Bari, Italy

    Piero Portincasa

  2. Department of Endocrinology & Nutrition, University of Navarra, CIBEROBN, IdiSNA, Clinica Universidad de Navarra, Pamplona, Spain

    Gema Frühbeck

  3. Department of Cardiology, University Medical Center, Utrecht, The Netherlands

    Hendrik M. Nathoe

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Peleg, H., Ben-Chetrit, E. (2021). Impact of Endocrine Disorders on Autoimmune Diseases. In: Portincasa, P., Frühbeck, G., Nathoe, H.M. (eds) Endocrinology and Systemic Diseases. Endocrinology. Springer, Cham. https://doi.org/10.1007/978-3-319-68729-2_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-68729-2_8

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-68728-5

  • Online ISBN: 978-3-319-68729-2

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation